vs
Side-by-side financial comparison of AbbVie (ABBV) and SYNTEC OPTICS HOLDINGS, INC. (OPTX). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $7.5M, roughly 2214.2× SYNTEC OPTICS HOLDINGS, INC.). AbbVie runs the higher net margin — 10.9% vs -4.6%, a 15.5% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs 2.5%). AbbVie produced more free cash flow last quarter ($4.9B vs $-4.4K). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 9.5%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
ABBV vs OPTX — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $7.5M |
| Net Profit | $1.8B | $-343.8K |
| Gross Margin | 72.6% | 23.6% |
| Operating Margin | 27.3% | 4.2% |
| Net Margin | 10.9% | -4.6% |
| Revenue YoY | 10.0% | 2.5% |
| Net Profit YoY | 8354.5% | 77.7% |
| EPS (diluted) | $1.02 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | $7.5M | ||
| Q3 25 | $15.8B | $7.0M | ||
| Q2 25 | $15.4B | $6.6M | ||
| Q1 25 | $13.3B | $7.1M | ||
| Q4 24 | $15.1B | $7.3M | ||
| Q3 24 | $14.5B | $7.9M | ||
| Q2 24 | $14.5B | $7.0M | ||
| Q1 24 | $12.3B | $6.3M |
| Q4 25 | $1.8B | $-343.8K | ||
| Q3 25 | $186.0M | $-1.4M | ||
| Q2 25 | $938.0M | $-343.9K | ||
| Q1 25 | $1.3B | $323.7K | ||
| Q4 24 | $-22.0M | $-1.5M | ||
| Q3 24 | $1.6B | $-13.3K | ||
| Q2 24 | $1.4B | $281.8K | ||
| Q1 24 | $1.4B | $-1.2M |
| Q4 25 | 72.6% | 23.6% | ||
| Q3 25 | 66.4% | 12.3% | ||
| Q2 25 | 71.8% | 24.4% | ||
| Q1 25 | 70.0% | 32.7% | ||
| Q4 24 | 70.9% | 13.5% | ||
| Q3 24 | 70.9% | 23.3% | ||
| Q2 24 | 70.9% | 31.0% | ||
| Q1 24 | 66.7% | 11.3% |
| Q4 25 | 27.3% | 4.2% | ||
| Q3 25 | 12.1% | -17.5% | ||
| Q2 25 | 31.7% | -2.2% | ||
| Q1 25 | 28.0% | 7.5% | ||
| Q4 24 | -9.9% | -19.6% | ||
| Q3 24 | 26.5% | 1.4% | ||
| Q2 24 | 27.6% | 2.3% | ||
| Q1 24 | 22.7% | -22.5% |
| Q4 25 | 10.9% | -4.6% | ||
| Q3 25 | 1.2% | -20.6% | ||
| Q2 25 | 6.1% | -5.2% | ||
| Q1 25 | 9.6% | 4.6% | ||
| Q4 24 | -0.1% | -21.0% | ||
| Q3 24 | 10.8% | -0.2% | ||
| Q2 24 | 9.5% | 4.0% | ||
| Q1 24 | 11.1% | -19.3% |
| Q4 25 | $1.02 | $-0.01 | ||
| Q3 25 | $0.10 | $-0.04 | ||
| Q2 25 | $0.52 | $-0.01 | ||
| Q1 25 | $0.72 | $0.01 | ||
| Q4 24 | $-0.03 | $-0.05 | ||
| Q3 24 | $0.88 | $0.00 | ||
| Q2 24 | $0.77 | $0.01 | ||
| Q1 24 | $0.77 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | — |
| Total DebtLower is stronger | $58.9B | $2.6M |
| Stockholders' EquityBook value | $-3.3B | $9.5M |
| Total Assets | $134.0B | $24.3M |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | — | ||
| Q1 24 | $18.1B | — |
| Q4 25 | $58.9B | $2.6M | ||
| Q3 25 | $63.0B | $2.7M | ||
| Q2 25 | $63.0B | $2.9M | ||
| Q1 25 | $64.5B | $3.0M | ||
| Q4 24 | $60.3B | $3.1M | ||
| Q3 24 | $58.5B | $3.2M | ||
| Q2 24 | $58.0B | $2.8M | ||
| Q1 24 | $63.8B | $3.0M |
| Q4 25 | $-3.3B | $9.5M | ||
| Q3 25 | $-2.6B | $9.8M | ||
| Q2 25 | $-183.0M | $11.0M | ||
| Q1 25 | $1.4B | $11.4M | ||
| Q4 24 | $3.3B | $11.0M | ||
| Q3 24 | $6.0B | $12.1M | ||
| Q2 24 | $6.8B | $12.1M | ||
| Q1 24 | $8.0B | $11.9M |
| Q4 25 | $134.0B | $24.3M | ||
| Q3 25 | $133.9B | $24.6M | ||
| Q2 25 | $137.2B | $25.3M | ||
| Q1 25 | $136.2B | $26.3M | ||
| Q4 24 | $135.2B | $26.0M | ||
| Q3 24 | $143.4B | $27.3M | ||
| Q2 24 | $141.9B | $25.8M | ||
| Q1 24 | $148.9B | $24.6M |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | 45.44× | 0.26× | ||
| Q4 24 | 18.15× | 0.28× | ||
| Q3 24 | 9.70× | 0.26× | ||
| Q2 24 | 8.56× | 0.23× | ||
| Q1 24 | 7.97× | 0.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $-3.9K |
| Free Cash FlowOCF − Capex | $4.9B | $-4.4K |
| FCF MarginFCF / Revenue | 29.4% | -0.1% |
| Capex IntensityCapex / Revenue | 2.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $28.3K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | $-3.9K | ||
| Q3 25 | $7.0B | $535.3K | ||
| Q2 25 | $5.2B | $-158.0K | ||
| Q1 25 | $1.6B | $299.3K | ||
| Q4 24 | $7.0B | $623.8K | ||
| Q3 24 | $5.4B | $417.3K | ||
| Q2 24 | $2.3B | $-1.7M | ||
| Q1 24 | $4.0B | $-289.8K |
| Q4 25 | $4.9B | $-4.4K | ||
| Q3 25 | $6.6B | $496.3K | ||
| Q2 25 | $4.9B | $-548.1K | ||
| Q1 25 | $1.4B | $84.6K | ||
| Q4 24 | $6.8B | $12.1K | ||
| Q3 24 | $5.2B | $43.8K | ||
| Q2 24 | $2.0B | $-1.9M | ||
| Q1 24 | $3.8B | $-385.1K |
| Q4 25 | 29.4% | -0.1% | ||
| Q3 25 | 42.1% | 7.1% | ||
| Q2 25 | 31.7% | -8.4% | ||
| Q1 25 | 10.5% | 1.2% | ||
| Q4 24 | 44.7% | 0.2% | ||
| Q3 24 | 35.9% | 0.6% | ||
| Q2 24 | 14.0% | -26.5% | ||
| Q1 24 | 31.3% | -6.2% |
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 2.4% | 0.6% | ||
| Q2 25 | 1.7% | 5.9% | ||
| Q1 25 | 1.8% | 3.0% | ||
| Q4 24 | 1.9% | 8.4% | ||
| Q3 24 | 1.7% | 4.7% | ||
| Q2 24 | 1.7% | 2.3% | ||
| Q1 24 | 1.6% | 1.5% |
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | 0.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | -6.01× | ||
| Q1 24 | 2.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
